CGON
COM:CGONCOLOGY
CG Oncology
- Stock
Last Close
32.34
22/11 21:00
Market Cap
2.26B
Beta: -
Volume Today
397.20K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | Sep '24 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -8.39M - | -8.67M 3.28% | -11.62M 34.04% | -12.21M 5.08% | -16.12M 32.02% | -16.93M 5.06% | -18.90M 11.63% | -20.41M 7.95% | |
depreciation and amortization | 4K - | 4K 0% | 4K 0% | 5K 25% | 4K 20% | 4K 0% | 7K 75% | 21K 200% | |
deferred income tax | |||||||||
stock based compensation | 148K - | 179K 20.95% | 177K 1.12% | 394K 122.60% | 778K 97.46% | 1.52M 94.99% | 2.65M - | ||
change in working capital | 1.30M - | 373K 71.40% | 286K 23.32% | 618K 116.08% | 2.16M 249.84% | -8.40M 488.48% | 3.01M 135.80% | 3.40M 13.14% | |
accounts receivables | 45K - | ||||||||
inventory | |||||||||
accounts payables | 186K - | -9K 104.84% | 49K 644.44% | 590K 1,104.08% | 1.38M 134.24% | 1.42M 2.53% | -168K 111.86% | -415K 147.02% | |
other working capital | 1.12M - | 382K 65.83% | 780K - | -9.82M 1,358.46% | 3.27M 133.26% | 3.77M 15.53% | |||
other non cash items | 107K - | 125K 16.82% | 621K 396.80% | 87K 85.99% | -14K 116.09% | -2.09M 14,857.14% | -50K 97.61% | -1.59M 3,072% | |
net cash provided by operating activities | -6.83M - | -7.99M 16.94% | -10.79M 35.06% | -10.85M 0.56% | -16.06M 48.08% | -26.01M 61.96% | -16.12M 38.03% | -15.92M 1.25% | |
investments in property plant and equipment | 1K - | -6K - | 6K 200% | -12K - | -14K 16.67% | 1K 107.14% | |||
acquisitions net | |||||||||
purchases of investments | -55.34M - | -78.70M 42.22% | -32.35M 58.90% | -27.09M 16.25% | -379.47M 1,300.73% | -453.30M 19.45% | -206.34M 54.48% | -169.24M 17.98% | |
sales maturities of investments | 135.71M - | 145.87M - | 170.13M 16.63% | 201.24M 18.29% | |||||
other investing activites | -55.34M - | -78.70M 42.22% | 16.94M - | -307.43M 1,914.51% | |||||
net cash used for investing activites | -55.34M - | -78.70M 42.22% | 103.36M 231.33% | -162.80M 257.51% | 16.94M 110.41% | -307.44M 1,914.58% | -36.23M 88.22% | 32.01M 188.34% | |
debt repayment | -833K - | -15.39M 1,747.54% | -67K 99.56% | -1K 98.51% | -365K 36,400% | ||||
common stock issued | 148K - | 403.02M - | 40K 99.99% | ||||||
common stock repurchased | |||||||||
dividends paid | |||||||||
other financing activites | 56.70M - | 68K 99.88% | -3.15M - | -3.39M 7.49% | 2.17M - | ||||
net cash used provided by financing activities | 56.70M - | -765K 101.35% | -15.22M 1,890.20% | 105.88M 795.41% | -2.89M 102.73% | 402.66M 14,037.63% | 40K 99.99% | 2.17M 5,317.50% | |
effect of forex changes on cash | |||||||||
net change in cash | -5.47M - | -87.45M 1,499.31% | 77.35M 188.45% | -67.77M 187.61% | -2.01M 97.04% | 69.20M 3,548.03% | -52.31M 175.59% | 18.25M 134.89% | |
cash at beginning of period | 93.61M - | 88.14M 5.84% | 693K 99.21% | 78.04M 11,161.04% | 10.27M 86.84% | 8.27M 19.54% | 77.47M 837.19% | 25.16M 67.52% | |
cash at end of period | 88.14M - | 693K 99.21% | 78.04M 11,161.04% | 10.27M 86.84% | 8.27M 19.54% | 77.47M 837.19% | 25.16M 67.52% | 43.41M 72.55% | |
operating cash flow | -6.83M - | -7.99M 16.94% | -10.79M 35.06% | -10.85M 0.56% | -16.06M 48.08% | -26.01M 61.96% | -16.12M 38.03% | -15.92M 1.25% | |
capital expenditure | 1K - | -6K - | 6K 200% | -12K - | -14K 16.67% | 1K 107.14% | |||
free cash flow | -6.83M - | -7.99M 16.96% | -10.79M 35.14% | -10.84M 0.44% | -16.06M 48.16% | -26.02M 62.03% | -16.13M 38.00% | -15.92M 1.34% |
All numbers in (except ratios and percentages)